Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
Abstract
In this article of EBioMedicine, Lin M-H et al. [[1]Lin H.M. Mak B. Yeung N. Huynh K. Meikle T.G. Mellett N.A. et al.Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.EBioMedicine. 2021; 72103625Summary Full Text Full Text PDF Scopus (9) Google Scholar], used lipidomics analysis on prostate cancer (PCa) patients undergoing androgen/androgen receptor targeting therapies to show that ceramide and its...
Paper Details
Title
Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
Published Date
Dec 1, 2021
Journal
Volume
74
Pages
103696 - 103696
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History